E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with C
>
Issuers starting with C, CV only
>
All stories on Chemed Corp.
>
Stories on Chemed Corp., CV only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Chemed Corp.
3/18/2014
CV
Chemed modifies conversion price on 1.875% convertibles due 2014
2/19/2014
CV
Market Commentary:
Tesla in focus, shares surge after hours; Chemed pulls back in line with stock; Genco down
2/18/2014
CV
Market Commentary:
Convertibles thinly traded to start week; Ctrip.com paper higher in line; Chemed expands
10/29/2013
CV
Market Commentary:
Midday Commentary: Chemed down outright, expands on hedge; Volcano drops in line with shares
10/29/2013
CV
Market Commentary:
Volcano drops outright, flat to better on hedge; Chemed down outright, expands on hedge
5/3/2013
CV
Market Commentary:
Chemed expands on hedge on lawsuit news; TTM adds on hedge; Regeneron steady to lower
4/16/2013
CV
Market Commentary:
NetApp active, in line with shares; Intel trades ahead of earnings; Chemed flat to higher
10/29/2012
CV
Market Commentary:
Convertibles silent: U.S. equity, bond markets shut as Sandy approaches; data delays eyed
8/10/2012
CV
Market Commentary:
MGM better on outright demand; Janus adds on investment stake; Hornbeck trades up, in line
10/31/2007
CV
Market Commentary:
Equinix surges on earnings; Newmont shines; Chemed scares investors; debt strangles CommScope
5/14/2007
CV
Chemed greenshoe fully exercised, lifts 1.875% convertibles to $200 million
5/9/2007
CV
New Issue: Chemed prices upsized $180 million seven-year convertibles to yield 1.875%, up 22.5%
5/9/2007
CV
Market Commentary:
Chemed, Sciele soar in debuts; Alesco quiet in gray, Chesapeake draws mixed views; CACI, L-1 plan deals
5/8/2007
CV
Chemed talks $160 million seven-year convertibles at 1.875%-2.375%, up 17.5%-22.5%
5/8/2007
CV
Market Commentary:
Armor holds firm on merger hopes; Chemed higher, Sciele quiet in gray; Chesapeake, Alesco launch deals
5/7/2007
CV
Market Commentary:
Armor climbs on BAE buyout; Yahoo! fades with merger hopes; Gold Reserve, Chemed launch deals
5/7/2007
CV
Chemed to price $160 million seven-year convertibles Tuesday
5/28/2004
CVHY
S&P rates Chemed notes
5/27/2004
CV
Chemed says 417,256 trust preferreds converted ahead of redemption
4/7/2004
CV
Roto-Rooter calls Chemed convertibles
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
